Image from Google Jackets

Oxidative Stress Increases Susceptibility of Mycobacterium tuberculosis to Isoniazid

Tipo de material: TextoTextoSeries ; Antimicrobial Agents and Chemotherapy, 46(9), p.2765-2771, 2002Trabajos contenidos:
  • Bulatovic,V.M
  • Wengenack, N.L
  • Uhl, J.R
  • Hall, L
  • Roberts, G.D
  • Cockerill, F.R
  • Rusnak, F
Recursos en línea: Resumen: Isoniazid is a first-line antibiotic used in the treatment of infections caused by Mycobacterium tuberculosis. Isoniazid is a prodrug requiring oxidative activation by the catalase-peroxidase hemoprotein, KatG. Resistance to isoniazid can be obtained by point mutations in the katG gene, with one of the most common being a threonine-for-serine substitution at position 315 (S315T). The S315T mutation is found in more than 50
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)

Isoniazid is a first-line antibiotic used in the treatment of infections caused by Mycobacterium tuberculosis. Isoniazid is a prodrug requiring oxidative activation by the catalase-peroxidase hemoprotein, KatG. Resistance to isoniazid can be obtained by point mutations in the katG gene, with one of the most common being a threonine-for-serine substitution at position 315 (S315T). The S315T mutation is found in more than 50

There are no comments on this title.

to post a comment.